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Abstract
Three groups of phosphoproteins have been distinguished, basing on the velocity and extent of phosphorylation in
platelets stimulated with collagen. pp60cÿsrc constituted the first group; the increase in its phosphorylation was the highest
and most rapid (maximal in 30 s after the addition of collagen). pp80/85 and non-identified protein of 65 kDa formed the
second group; the increase in their phosphorylation was twice smaller than that of pp60cÿsrc, and reached its maximum 60 s
after the addition of collagen. pp120, pp72syk, and two non-identified phosphoproteins of 90 and 75 kDa constituted the third
group; the increase in their phosphorylation was 4^10-fold lower than that of pp60cÿsrc and reached its maximum after 180 s.
We conclude that the phosphorylation of pp60cÿsrc is important for the change of shape of platelets, the phosphorylation of
pp80/85 and pp65 for the initiation of the formation of aggregates and the phosphorylation of the third group of
phosphoproteins for the formation of massive aggregates. This conclusion was supported by using a monoclonal anti-GPIb
antibody, which did not inhibit the shape change of platelets and did not inhibit pp60cÿsrc phosphorylation. This antibody
inhibited aggregate formation as well as tyrosine phosphorylation of proteins belonging to the second and the third group of
phosphoproteins. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Fibrillar collagen, one of the most thrombogenic
agents of the vessel wall [1], interacts with platelets
by several mechanisms which can be divided into
direct (primary) and indirect (secondary). Primary
mechanisms are mediated by components present
on the surface of unactivated platelets, while secon-
dary mechanisms involve receptors expressed only
upon activation of platelets. Although several plate-
let proteins have been proposed to be primary colla-
gen receptors, i.e. collagen-glucosyl transferase [2],
¢bronectin [3], 65-kDa protein [4], GPIIb^IIIa [5,6],
GPIa^IIa [7^12], factor XIII [13], glycoprotein VI
[14^16] and glycoprotein IV [17^19], only a few of
them have gained general acceptance. The strongest
evidence supporting such a role for GPIa^IIa and
GPVI has come from clinical studies. Patients de¢-
cient in GPIa^IIa and GPVI were described to have
impaired or lack collagen-induced aggregation and
adhesion [7,8,14^16]. There is some evidence that
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nesulfonic acid; PBS, phosphate-bu¡ered saline; BME, 2-mer-
captoethanol; PAF, platelet -activating factor; ASA, acetylsali-
cylic acid
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glycoprotein IV (CD36) functions at the earliest
stages of collagen adhesion as a platelet collagen re-
ceptor although CD36 de¢cient platelets adhere nor-
mally to collagen types I, III and IV. CD36 de¢cient
platelets show also normal aggregation induced by
collagen. CD36 seems to be essential for collagen
type V-induced platelet interaction although the
physiological importance of such interaction is ques-
tionable [19^23].
There is general agreement on the involvement of
GPIIb^IIIa in mediating secondary adhesion through
macromolecules released from activated platelets or
present in plasma, such as ¢bronectin, von Wille-
brand’s factor (vWf) and thrombospondin (TSP)
[24]. The role of GPIb in mediating shear-dependent
platelet adhesion is also well characterized through
studies with Bernard^Soulier platelets. The primary
role of GPIb is to bind to vWF on exposed suben-
dothelium. The GpIb is expressed on unactivated
platelets, but is active at high shear rates [25,26].
Platelets show high levels of non-receptor protein
tyrosine kinase (PTK) activity, largely due to the
high concentration of pp60cÿsrc and pp72syk as well
as other PTKs, such as pp60fyn, pp54/58lyn, pp62hck,
pp62yes and pp125FAK [27^30]. The activation of pla-
telets with many agonists, such as thrombin, collagen
and platelet -activating factor (PAF), leads to many
events (including shape change, secretion, binding of
soluble ¢brinogen to its receptor and aggregation)
that are thought to be regulated through a number
of intracellular signalling pathways, including PTK
activation [31^34]. Collagen-induced platelet activa-
tion di¡ers in many ways from the activation in-
duced by soluble activators, such as thrombin.
Firstly, cyclic AMP does not inhibit collagen-induced
platelet signal transduction, whereas it inhibits the
signal transduction induced by ADP, thrombin and
a thromboxane mimetic U-46619 [35,36]. Secondly,
collagen-induced platelet stimulation involves the ty-
rosine phosphorylation-dependent activation of
phospholipase CQ2, while that induced by several
other agonists does not [37^39]. Thirdly, collagen is
the only physiological platelet agonist that has been
identi¢ed to induce phosphorylation of the FcRQ
chain enabling binding of pp72syk and the assembly
of a signaling complex independently from phospho-
lipase C (PLC) activity [39^41]. The cytoplasmic tail
of the FcRQ chain contains an immunoreceptor tyro-
sine-based activation motif (ITAM). The association
of pp72syk with FcRQ chain appears to be mediated
through the tandem SH2 domains in pp72syk and the
ITAM motif of this receptor [38,40,41].
For the purpose of this study, we have concen-
trated on the role of protein phosphorylation during
di¡erent stages of platelet activation induced by col-
lagen. The data demonstrated an increase in tyrosine
phosphorylation of many proteins upon collagen
treatment. Three groups of phosphoproteins were
distinguished based on the velocity and extent of
phosphorylation. The pp60cÿsrc belongs to the ¢rst
group since the increase in its phosphorylation was
the highest and most rapid. The phosphorylation of
pp60cÿsrc was found to be important for the early
activation events concerning the change of shape of
platelets. The phosphorylation of the second and
third group of proteins was important for the later
stages of collagen-induced activation connected with
the aggregates formation. These ¢ndings were sup-
ported by the use of anti-Ib monoclonal antibody
PO14, which neither inhibited the shape change nor
the pp60cÿsrc phosphorylation. PO14 inhibited aggre-
gation as well as tyrosine phosphorylation of the
proteins belonging especially to the third group.
2. Materials and methods
Fibrillar equine tendon collagen type I was from
Chrono-Log. Anti-phosphotyrosine monoclonal IgG
4G10 and monoclonal anti-src, pp80/85, pp120 as
well as polyclonal anti-syk antibodies were from Up-
state Biotechnology. A monoclonal antibody PO14
(clone name 105.12B12H3) against GPIb was a gen-
erous gift from Dr. C. de Romeuf (Hemostasis Re-
search Laboratories, Lille, France). Rainbow protein
molecular weight markers were from Amersham. All
other chemicals were purchased from Sigma.
2.1. Preparation of human platelets
Washed platelets were prepared from human
blood anticoagulated with ACD (citrite acid^cit-
rate^dextrose) obtained from volunteer donors as
described previously, with some minor modi¢cation
[17,42]. Brie£y, platelet-rich plasma was obtained by
centrifuging the whole blood at 2000Ug for 20 min
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at 22‡C. For the preparation of the washed platelets,
the pH of the platelet-rich plasma was adjusted to
6.5 with citric acid (0.2 M) and made 1 Wg/ml with
respect to prostaglandin E1. Then, the platelets were
sedimented by centrifugation at 1000Ug for 10 min
and the pellet was resuspended in the platelet wash
bu¡er (5.5 mM dextrose, 128 mM NaCl, 4.26 mM
Na2HPO4, 7.46 mM NaH2PO4, 4.77 mM trisodium
citrate, and 2.35 mM citric acid, pH 6.5) supple-
mented with 0.35% bovine serum albumin. The pla-
telet suspension was then centrifuged at 2000Ug for
10 min to sediment the platelets. The platelets were
washed twice with the platelet wash bu¡er and ¢nally
were suspended in the modi¢ed HEPES^Tyrode’s
bu¡er (136 mM NaCl, 5.5 mM dextrose, 2 mM
MgCl2, 0.47 mM NaH2P04, 16.6 mM NaHC03,
2.7 mM KCl, 10 mM HEPES, pH 7.35). The platelet
were counted by the photometric method as de-
scribed by Walkowiak et al. [43].
2.2. Collagen-induced platelet aggregation
Washed platelets suspended in modi¢ed HEPES^
Tyrode’ bu¡er at 4U108/ml were used for aggrega-
tion study. The platelets were incubated with mono-
clonal anti-Ib antibody for 30 min at 22‡C. Platelet
aggregation was monitored using the Labor Apact
aggregometer. The aggregation was terminated 10,
30, 60, 120, and 180 s after the addition of collagen
(1 Wg/ml) by solubilizing platelets in the sample buf-
fer (2% SDS, 0.062 M Tris-HCl, 0.01% Bromophenol
blue, 10% glycerol, pH 6.8) containing 2 mM PMSF,
2 mM NEM and 1 mM sodium orthovanadate. The
samples were immediately boiled for 10 min and
stored at 320‡C, until used for SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) and immunoblot-
ting. Stock solution of 100 mM sodium orthovana-
date was prepared according to Goodno [44]. Brie£y,
Na3V04 was dissolved in water, pH was adjusted to
10.0 with 6 N HCl. Polymeric species of vanadate
(orange-yellow) were destroyed by boiling the solu-
tion until colorless, followed by rechecking the pH of
the cooled solution.
2.3. SDS-PAGE
SDS-PAGE was performed by the method of
Laemmli [45] using a 7% running gel. The samples
were reduced by heating at 100‡C for 5 min with 5%
BME. Rainbow molecular weight markers, contain-
ing myosin (200 kDa), phosphorylase (97 kDa), bo-
vine serum albumin (69 kDa), ovalbumin (46 kDa),
carbonic anhydrase (30 kDa), trypsin inhibitor
(21.5 kDa) and lysozyme (14.3 kDa) were run on
each gel. Proteins from 2U107 platelets per lane
(30 Wg) were separated by SDS-PAGE and trans-
ferred onto nitrocellulose ¢lters. The parallel gels
were stained with Coommassie blue to ensure that
equivalent amounts of proteins were added to each
lane.
2.4. Immunoblotting
The Bio-Rad trans-blot cell was used to transfer
proteins from polyacrylamide gels onto nitrocellulose
sheets. The transfer was done at 50 mA overnight.
The detection of phosphotyrosine-containing pro-
teins was carried out according to the UBI protocol,
using a Western-blot kit for anti-phosphotyrosine
monoclonal antibody. Brie£y, the blots were incu-
bated in PBS containing 3% skim milk for 1 h at
room temperature. After blocking with milk, the
blots were incubated with anti-phosphotyrosine
monoclonal antibody at the concentration of 1 Wg/
ml overnight at 4‡C, washed and incubated with al-
kaline phosphatase-conjugated secondary antibody
at the concentration of 0.5 Wg/ml for 2 h at room
temperature. Protein bands were visualized by alka-
line phosphatase detection system (UBI). Before the
detection of tyrosine phosphorylated proteins, nitro-
celluloses were stained with Panceau S to ensure that
equivalent amounts of proteins were added to each
lane. Speci¢city of the 4G10 anti-phosphotyrosine
antibody was con¢rmed by the method of Nakamura
and Yamamura [31]. Tyrosine-phosphorylated and
Coommassie-stained protein bands were quantitated
using the GelImage system, Pharmacia LKB. To
quantify the densitometric scans, the background
was subtracted and the area for each protein peak
was determined.
The identi¢cation of phosphotyrosine-containing
proteins was performed using monoclonal anti-src,
anti-pp120, and anti-pp80/85 antibodies and anti-
syk rabbit serum. Protein transfer and blots process-
ing was done as in the case of phosphotyrosine anti-
bodies with the exception that all monoclonal anti-
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bodies were used at the concentration of 2 Wg/ml and
the anti-syk rabbit serum was used at dilution
1:1000.
3. Results
Washed platelets were activated with collagen
(1 Wg/ml) and the extent of aggregation was moni-
tored in an aggregometer. The aggregation of human
platelets was terminated before the shape change
took place (10 s after the addition of collagen), after
the shape change (30 s after the addition of collagen),
at the onset of aggregate formation (60 s after the
addition of collagen), at the beginning of the com-
pletion of aggregation (120 s after the addition of
collagen), and at the completion of aggregation
(180 s after the addition of collagen) by solubilizing
platelets in the sample bu¡er. Solubilized platelets
were transferred to nitrocellulose and phosphotyro-
sine containing proteins were detected using 4G10
monoclonal anti-phosphotyrosine antibody.
As shown in Fig. 1A, in unstimulated platelets,
four tyrosine phosphorylated proteins were detected:
Fig. 1. Protein tyrosine phosphorylation during collagen-induced activation and aggregation. Washed platelets suspended in a modi¢ed
HEPES^Tyrode’s bu¡er were aggregated as described in Section 2. (A) Proteins were analyzed by SDS-PAGE on 8% polyacrylamide
gels and by subsequent Western blotting with an anti-phosphotyrosine antibody, followed by alkaline phosphatase visualization. Lanes
1, 2, 3, 4, 5, platelets 180, 120, 60, 30 and 10 s after the addition of collagen (1 Wg/ml); lane 6, resting platelets. Molecular weight
markers are shown on the right. Each lane contains proteins from 2U107 platelets. (B) Platelets aggregated by collagen after 180 s
were solubilized and proteins were separated by SDS-PAGE on 8% polyacrylamide gels and then transferred to nitrocellulose. The
platelet proteins were stained with antibodies speci¢c to phosphotyrosine (lane 1), pp60cÿsrc (lane 2), pp72syk (lane 3), pp80/85 (lane 4)
and pp120 (lane 5). The molecular masses of marker proteins are shown on the right. (C) Time-course aggregation was monitored in
the Labor-Apact aggregometer as described in Section 2. Arrows indicate the addition of collagen (1 Wg/ml) (representative experi-
ment). The experiments shown were reproduced on at least three occasions.
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a major band of 60 kDa and minor bands at 120, 80
and 65 kDa. Activation with collagen increased the
phosphorylation of these bands and caused a number
of proteins to become phosphorylated at tyrosine.
After 30 s, there were 13 proteins with molecular
weight of 120, 115, 112, 90, 82, 80, 70, 67, 65, 60,
58, 56 and 48 kDa phosphorylated. The extent of
phosphorylation of these proteins increased after 60
and 120 s. At 180 s, after the addition of collagen,
two additional phosphoproteins of 78 and 75 kDa
appeared. To identify some of these proteins, platelet
aggregates obtained 180 s after the addition of colla-
gen were separated by SDS-PAGE, followed by
transferring to nitrocellulose and blotting with the
anti-phosphotyrosine antibodies. Protein bands
were identi¢ed by: (a) apparent molecular weight;
and (b) immunoblotting with mono- and polyclonal
antibodies speci¢c to major phosphoproteins. As
shown in Fig. 1B, the major band, showing molec-
ular weight of 60 kDa, corresponded to pp60cÿsrc.
The other bands, showing molecular weights of 120
and 70 kDa, corresponded to pp120 (the pp60cÿsrc
substrate) and pp72syk, respectively. A triad at about
82, 80 and 78 kDa corresponded to the forms of
pp80/85, the substrate of pp60cÿsrc. The other phos-
phoproteins were not identi¢ed; however, the pro-
teins of molecular masses of 65, 58 and 56 kDa
may represent the src family kinases pp62yes and
pp54/58lyn, respectively. The identi¢cation of some
of these proteins, like pp72syk and pp60cÿsrc, by im-
munoprecipitation followed by immunoblotting with
anti-phosphotyrosine antibody gave identical results
(not shown).
In order to compare quantitatively the appearance
of phosphoproteins in collagen-induced activation
and aggregation of platelets nitrocelluloses contain-
ing phosphorylated proteins were densitometrically
scanned and quantitated using the GelImage system.
Fig. 2 shows that three groups of phosphoproteins
can be distinguished, basing on the velocity and ex-
tent of phosphorylation. pp60cÿsrc constituted the
¢rst group; the increase in its phosphorylation was
the highest and most rapid up to 30 s after the addi-
tion of collagen. The phosphorylation of this tyro-
sine kinase remained basically at the same level 180 s
after the addition of collagen A kinase assay of
pp60cÿsrc immunoprecipitates showed similar in-
crease in pp60cÿsrc phosphorylation during a time
course of collagen-induced platelet activation (results
not shown).
The second group consisted of pp80/85 and non-
identi¢ed protein of 65 kDa. The increase in their
phosphorylation was 2-fold lower than that of
pp60cÿsrc (i.e. 180 s after the addition of collagen),
and reached its maximum 60 s after the addition of
collagen. pp120, pp72syk, and two non-identi¢ed
phosphoproteins of 90 and 75 kDa were in the third
group. The increase in their phosphorylation was
4^10-fold lower than that of pp60cÿsrc (i.e. 180 s after
the addition of collagen) and reached its maximum
at 180 s.
To help evaluate the role of tyrosine phosphoryla-
tion in platelet activation and aggregation we have
tested the in£uence of monoclonal anti-Ib (PO14)
antibody. Platelet aggregation in the presence of in-
creasing concentration of PO14 was measured 180 s
after the addition of collagen. The result in Fig. 3
shows that PO14 inhibited platelet aggregation in a
concentration-dependent manner. PO14 had no e¡ect
on platelet shape change, as shown in Fig. 3A.
In order to compare quantitatively the e¡ect of
PO14 on the phosphorylation of platelet proteins,
Fig. 2. Time course of platelet protein phosphorylation during
collagen-induced platelet activation and aggregation. Platelet ac-
tivation and aggregation was terminated 10, 30, 60, 120 and
180 s after the addition of collagen as described in Section 2.
Platelet proteins were analyzed by SDS-PAGE on 8%
polyacrylamide gels and by subsequent Western blotting with
an anti-phosphotyrosine antibody, followed by alkaline phos-
phatase visualisation. Phosphoprotein bands were quantitated
using GelImage system. To quantify densitometric scans, the
background was subtracted and the area for each peak was de-
termined. The results are the mean from three experiments.
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nitrocelluloses containing the proteins obtained from
the aggregated platelets, following immunoblotting
with the anti-phosphotyrosine antibodies, were den-
sitometrically scanned and quantitated using the
GelImage system. Since not all the phosphoproteins
were detectable by this system, Fig. 4 shows only the
inhibitory e¡ect of PO14 on the phosphorylation of
4 proteins. As it is seen in Fig. 4, P014 a¡ected
mostly the phosphorylation of pp72syk which was
decreased 3^6-fold when the antibody was used at
the concentration of 5^30 Wg/ml. The inhibition of
pp80/85 and pp65 was approximately twice smaller
than that seen in the case of pp72syk. The phosphor-
ylation of pp60cÿsrc was not a¡ected even at the con-
centration of 30 Wg/ml of anti-Ib, the highest concen-
tration tested which inhibited platelet aggregation by
90%. The inhibition of phosphorylation of pp120
was complete even at the concentration of 5 Wg/ml
of anti-Ib, the lowest concentration tested in these
sets of experiments (not shown).
4. Discussion
Activation and aggregation of platelets by collagen
is associated with tyrosine phosphorylation of many
platelet proteins. Based on the rate and extent of
phosphorylation they may be divided into three
groups: (a) pp60cÿsrc formed the ¢rst group, since
Fig. 4. The e¡ect of anti-Ib antibody on tyrosine phosphoryla-
tion of pp60cÿsrc, pp65, pp72syk and pp80/85. Platelets were ag-
gregated in the presence and absence of the anti-Ib antibody.
Platelets were incubated with the anti-Ib antibody for 30 min at
room temperature. Phosphotyrosine bands were visualised as
described in Section 2. Phosphoprotein bands were quantitated
using the GelImage system. Relative peak area (y-axis) is the
value obtained by dividing the peak area of the band from con-
trol aggregation (in the absence of antibody) by the peak area
in the presence of antibody. The results are the mean þ S.D.
from four experiments.
Fig. 3. The in£uence of anti-Ib antibody on platelet aggrega-
tion. Platelets were incubated with the anti-Ib antibody for 30
min at room temperature before aggregation. The aggregation
of platelets was measured 3 min after the addition of collagen
(1 Wg/ml), as described in Section 2. (A) Platelet aggregation
tracings from control platelets (not treated with PO14) (line 1)
and incubated with PO14 at concentrations 1, 5, 10 and 30 Wg/
ml (lines 2, 3, 4 and 5, respectively) are from one representative
of six independent experiments with similar results. Collagen
was added at the arrow. (B) Results are expressed as % of con-
trol aggregation (without antibody). The aggregation of control
platelets (not incubated with antibody was 70^90%. The results
are the mean þ S.D. from six experiments.
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the increase in the phosphorylation of this kinase
was the most rapid one. A two-fold increase was
already visible after 10 s (before the shape change)
and an almost 10-fold increase after 30 s (after the
shape change). The events taking place in platelets
after 10 and 30 s are de¢ned as early activation
events induced by collagen. Since the activation of
pp60cÿsrc was almost complete during 30 s it can be
concluded that the phosphorylation of this kinase is
very important for the early activation manifested by
the shape change. This conclusion was supported by
using monoclonal anti-Ib antibodies PO14, which
neither inhibited the shape change of platelets nor
the pp60cÿsrc phosphorylation. The rate and extent
of pp60cÿsrc phosphorylation induced by collagen is
comparable to that described with other agonists
[46]. Since the collagen-induced phosphorylation of
pp60cÿsrc was the most rapid one it is very likely, as
indicated earlier with thrombin [47], that the activa-
tion of this kinase is a prerequisite for phosphoryla-
tion of other kinases. (b) The second group consisted
of pp80/85 and non-identi¢ed protein of 65 kDa. The
increase in their phosphorylation reached maximum
after 60 s. The onset of aggregate formation was
observed at the same time. Thus, these two phospho-
proteins seem to be responsible for this event. pp80/
85 was primarily identi¢ed as a cytoskeleton-associ-
ated substrate for v-src in transformed cells. It did
not show any identity with the 85 kDa subunit of
phosphatidylinositol-3 kinase. The sequence of the
SH3 domain of pp80/85 showed the greatest identity
with other cytoskeleton-associated protein, such as
fodrin and myosin 1 [48]. pp80/85 was shown to be
present in platelets and was found previously to as-
sociate with pp60cÿsrc in thrombin-activated platelets.
Similarly to collagen, thrombin induced the phos-
phorylation of this protein as soon as after 1 min
[46]. In thrombin-activated platelets, pp60cÿsrc was
postulated to participate in the cytoskeletal changes
by phosphorylation of pp80/85 [46]. Probably the
same mechanism is responsible for shape change in
collagen-activated platelets. (c) pp72syk, pp120, and
two phosphoproteins of 75 and 90 kDa belonged to
the third group of phosphoproteins. The increase in
their phosphorylation started basically 120 s after the
addition of collagen. At this time, a massive aggre-
gate formation occurred, and the phosphoproteins
from the third group can be responsible for this phe-
nomenon.
pp72syk was found previously not to be phosphory-
lated on tyrosine in resting platelets [34]. Many ago-
nists, such as wheat germ agglutinin, thrombin, PAF,
collagen and thromboxane A2 mimetic U 44069,
were described previously to induce the activation
of pp72syk in platelets [49^53]. Thrombin rapidly in-
duced the phosphorylation of pp72syk [50]. The in-
crease in pp72syk activity was observed as early as 5 s
upon the thrombin treatment, it reached its maxi-
mum in 10 s and decreased to the basal level within
60 s in a calcium-dependent manner [50]. Our data
are consistent with this observation and indicate the
lack of phosphorylation of pp72syk in resting plate-
lets. They also show that the kinetics of the pp72syk
phosphorylation in the collagen-treated platelets dif-
fers from that described for the thrombin-treated
platelets. A very small increase in the phosphoryla-
tion of pp72syk (together with three other proteins of
120, 90 and 75 kDa) was observed up to 120 s after
the collagen addition. A rapid increase in its phos-
phorylation was seen after 120 s, which was coinci-
dent with massive aggregates formation. This may
suggest that thrombin elicits some intracellular sig-
nals which are not shared with collagen.
Our data also show some di¡erences from that
were described previously for the collagen-treated
platelets [39,53]. First, proteins of 54, 65, 75, 97
and 125 kDa were phosphorylated in the collagen-
treated platelets as described by Asazuma et al. [53].
The 75 kDa band consisted of two proteins, cortactin
and pp72syk. Thus, a total number of six phospho-
protein bands was found. We found 15 proteins to be
phosphorylated upon the comparable time of colla-
gen treatment. Secondly, the activation of pp60cÿsrc
showed only minimal changes upon the collagen
treatment in the previous work, while we found
that pp60cÿsrc phosphorylation increased several
times and that was much higher and faster than oth-
er proteins. Thirdly, Asazuma et al. [53] described
that the phosphorylation of pp72syk was very rapid;
it reached its peak after 30^60 s and then gradually
decreased. We show that the phosphorylation level of
pp72syk was very low up to 120 s after the addition of
collagen and a rapid increase in its phosphorylation
occurred thereafter. Several factors can account for
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the above discrepancies. Collagen at the concentra-
tion 50 Wg/ml from Hormon-Chemie was required
for the stimulation of platelets pretreated with
1 mM acetylsalicylic acid (ASA), as described by
Asazuma et al. [53]. We used the equine-tendon col-
lagen and the concentration of 1 Wg/ml of this colla-
gen was enough to induce the activation and aggre-
gation of platelets. The platelets used in our
experiments were not subjected to ASA treatment,
thus secondary e¡ects of thromboxane A2 generation
may contribute to our results.
The present data do not con¢rm observation that
there is a signi¢cant increase in tyrosine phosphory-
lation of pp72syk within 1 min after collagen treat-
ment of platelets [39]. The possible explanation of
this discrepancy is that the experimental conditions
used in both studies were di¡erent, i.e. treatment of
platelets with soluble collagen from bovine skin at
concentration 200 Wg/ml under non-stirring condi-
tions may account for the di¡erences.
The general importance of pp72syk activation for
the collagen-induced aggregation of platelets was
shown previously [39] by using a pp72syk-selective
kinase inhibitor, piceatannol, which inhibited both
kinase activity of pp72syk and platelet aggregation.
Piceatannol also completely inhibited platelet shape
change implying a role for pp72syk in the initial col-
lagen-induced events. Additionally, since activation
of pp72syk occurred even in the absence of platelet
aggregation and K2L1 integrin engagement a role for
pp72syk upstream of platelet aggregation was postu-
lated [39]. Our ¢ndings on the kinetics of pp72syk
phosphorylation are in accordance with the report
of Fuji et al. [51].
pp120, a phosphoprotein which like pp72syk be-
longs to the third group, was previously identi¢ed
in chicken embryo ¢broblasts. Tyrosine phosphory-
lation of this protein correlated with src transforma-
tion in ¢broblasts. Monoclonal antibody against this
protein used in this study are speci¢c for pp120. This
antibody does not react with pp125FAK [54]. The
identity and function of pp120 as well as other pro-
teins of the molecular masses of 90, 75, 67, 65, 58, 56
and 48 have yet to be determined. We found that the
phosphorylation of pp72syk as well as pp120 was in-
hibited by PO14 antibody which inhibited the plate-
let aggregation and did not inhibit the shape change
of platelets. It clearly shows that these proteins play
a role in later signal transduction events associated
with the aggregation of platelets.
Previous studies, by using of anti-K2L1 monoclonal
antibody P1E6, showed that interaction of collagen
with K2L1 is directly connected with the phosphory-
lation of PLCQ2 and pp72syk [39]. However, the ex-
istence of K2L1-independent pathway of PLCQ2 and
pp72syk phosphorylation was indicated by the use of
two anti-K2L1 mAbs, 6F1 and mAb13, which did not
inhibit tyrosine phosphorylation of pp72syk and
PLCQ2 induced by collagen-related triple helical pep-
tide [55]. The use of K2L1 integrin blocking monoclo-
nal antibodies 6F1 and P1E6 demonstrated that ty-
rosine phosphorylation of FcRQ chain in response to
collagen is not dependent on the integrin K2L1 [39^
41]. The identity of the collagen receptor which leads
to tyrosine phosphorylation of FcRQ chain is not
known. However, recent studies indicate that GPVI
may be the signalling collagen receptor whose acti-
vation result in the tyrosine phosphorylation of the
FcRQ chain [56].
In response to collagen, the activity of pp60cÿsrc
from GPVI de¢cient platelets was comparable to
normal platelets. Such activation of pp60cÿsrc was
found to be K2L1-dependent because it was signi¢-
cantly inhibited in the presence of anti-K2L1 mAb
Gi9. By contrast, GPVI de¢cient platelets did not
exhibit detectable tyrosine phosphorylation of
pp72syk, pp125FAK and PLC-Q2 in response to colla-
gen. Therefore, the requirement of GPVI for the col-
lagen-stimulated tyrosine phosphorylation of these
proteins was indicated [57]. To evaluate the contri-
bution of GPIV to collagen induced protein tyrosine
phosphorylation GPIV de¢cient platelets were used
[58]. Since GPIV de¢cient platelets exhibited normal
protein tyrosine phosphorylation in response to col-
lagen, it seems that the role of this protein in colla-
gen-induced signalling events is minor when com-
pared with those of K2L1 and GPVI. Ruan et al.
initially reported that an anti-GPIbK antibody SZ 2
inhibited platelet aggregation induced by collagen
and PAF [59]. However, the e¡ect of this antibody
on protein tyrosine phosphorylation during collagen-
induced aggregation was not studied. It is notewor-
thy that anti-Ib antibody PO14 blocks both platelet
aggregation and protein tyrosine phosphorylation.
PO14 antibody was described previously as strong
inhibitors of ristocetin/vWf induced platelet aggluti-
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nation and thrombin-induced platelet aggregation
[60]. In addition, we demonstrate that PO14 inhibited
the aggregation of platelets as well as tyrosine phos-
phorylation of proteins belonging to the second and
third groups. These results suggest that GPIb plays
an important role in the collagen-mediated platelet
signalling occurring at the later stages of aggrega-
tion, i.e. at the stage of aggregate formation.
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